HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA approves Anthelios 40 sunscreen

This article was originally published in The Rose Sheet

Executive Summary

La Roche-Posay announces FDA approval of Anthelios 40 sunscreen, which contains "highest photostable UVA and UVB protection available in a sunscreen with Mexoryl SX," according to April 18 release. Product contains "unique, synergistic" combination of sun filters, and has been specifically tested for safety on individuals with photosensitive skin disorder, Polymorphous Light Eruption (PMLE). L'Oréal division notes that "up to 17% of the U.S. population alone experience symptoms related to PMLE as a result of UV (primarily UVA) exposure." Firm's Memoryl SX filter is touted as being uniquely photostable compared with other UVA protectants (1"The Rose Sheet" July 31, 2006, p. 3). Slated to launch in late spring, the sunscreen costs $29.50. Other Anthelios products include Anthelios SX Daily Moisturizing Cream with SPF 15 and Anthelios 15 Water Resistant Sunscreen Cream. Johnson & Johnson filed suit against L'Oréal in October 2006 charging the firm with false advertising and unfair competition, based on statements made in promotional materials for Anthelios SX (2"The Rose Sheet" Oct. 16, 2006, p. 5)...

You may also be interested in...



L’Oréal Sunscreen Promo Burns Reputation Of Competing Products – Suit

Promotional material for L'Oréal's La Roche-Posay Anthelios SX sunscreen moisturizer makes false statements that disparage competing sunscreen products,according to a lawsuit filed by Johnson & Johnson's Neutrogena Corporation and J&J Consumer Companies, Inc

L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter

L'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection this fall, the company announced July 24

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015387

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel